| Literature DB >> 28424047 |
Yoannah François1, Alain Vignal1, Caroline Molette1, Nathalie Marty-Gasset1, Stéphane Davail2, Laurence Liaubet1, Christel Marie-Etancelin3.
Abstract
BACKGROUND: The aim of this study was to analyse the mechanisms that underlie phenotypic quantitative trait loci (QTL) in overfed mule ducks by identifying co-localized proteomic QTL (pQTL). The QTL design consisted of three families of common ducks that were progeny-tested by using 294 male mule ducks. This population of common ducks was genotyped using a genetic map that included 334 genetic markers located across 28 APL chromosomes (APL for Anas platyrhynchos). Mule ducks were phenotyped for 49 traits related to growth, metabolism, overfeeding ability and meat and fatty liver quality, and 326 soluble fatty liver proteins were quantified.Entities:
Mesh:
Year: 2017 PMID: 28424047 PMCID: PMC5396126 DOI: 10.1186/s12711-017-0313-6
Source DB: PubMed Journal: Genet Sel Evol ISSN: 0999-193X Impact factor: 4.297
Fig. 1Experimental designs. I444: INRA Kaiya line; I37: INRA heavy Pekin line; BC: backcross
Fig. 2Two-dimensional gel electrophoresis representing a map of duck fatty liver soluble proteins
Trait descriptions
| Abbreviation | Unit | Meaning |
|---|---|---|
|
| ||
| BW12, BW28, BW42, BW70 | kg | Body weights at 12, 28, 42, 70 days of age |
| BWG12-28, BWG12-42, BWG12-70, BWG28-42, BWG28-70, BWG42-70 | g/d | Body weight gains (all combinations between 12, 28, 42 and 70 days of age) |
|
| ||
| CortL, CortH | ng/ml | Corticosterone level before and after stress |
| DeltaC | ng/ml | Difference in corticosterone level before and after stress |
|
| ||
| TG 2nd M, TG 10th M, TG 20th M | g/l | Plasma triglyceride level after 2nd, 10th and 20th meal |
| CHO 2nd M, CHO 10th M, CHO 20th M | g/l | Plasma cholesterol level after 2nd, 10th and 20th meal |
| GLU 2nd M, GLU 10th M, GLU 20th M | g/l | Plasma glucose level after 2nd, 10th and 20th meal |
| DFI | kg/d | Daily feed intake |
| BWbeg, BWend | kg | Body weight at beginning and end of overfeeding period |
| OWG | kg | Weight gain during the overfeeding period |
|
| ||
| CW | kg | Bled-plucked carcass weight |
| FLW | kg | Fatty liver weight |
| pmMW | kg |
|
| pmSFW | kg | Breast skin + subcutaneous fat weight |
| TSW | kg | Thigh + shank weight |
| AFW | kg | Abdominal fat weight |
|
| ||
| MR | % | Liver melting rate |
| LLipC, LProtC | % | Liver lipid and protein content |
| LColC | mg/g | Liver collagen content |
| LL*, La*, Lb* | Liver lightness, redness and yellowness | |
|
| ||
| MpH20, MpHu | Muscle pH 20 min | |
| MCookL, MvacL | % | Muscle cooking losses and muscle drip losses |
| MLipC | % | Muscle lipid contents |
| ML*, Ma*, Mb* | Muscle lightness, redness and yellowness | |
| Menergy | mJ | Energy needed to cut the muscle |
| MFmax | Maximal shear force | |
Fig. 3Sex-averaged genetic map in centiMorgan. Linkage groups (APL) were built using the Crimap software
Fig. 4Alpha-enolase spot localization on gel electrophoresis
Fig. 5Proteins with pQTL detected in different spots. Protein descriptions are in Additional file 1: Table S1
Sixty-six significant two-trait QTL for protein quantification and zootechnical traits
| APLa | Traits | Threshold | CLIP test | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Proteinb | Phenotype | Location (cM)c | LRTx | Confidence intervald | biQTL | UniQTL1 | UniQTL2 | Number of markers | Hype | |
| 3 | MDH1 (179) | BW12 | 61 | 27.155 | 48–69 | 0.66 | 2.09 | 3.44 | 29 | CL |
| 5 | ALDH7A1 (300) | BWG12-42 | 0 | 23.653 | 0–2 | 0.14 | 0.68 | 4.18 | 1 | CL |
| 5 | ACTB (159) | BWG12-42 | 1 | 18.018 | 0–2 | 1.05 | 3.06 | 4.18 | 1 | CL |
| 5 | VCP (283) | BWG12-42 | 1 | 20.996 | 0–2 | 0.38 | 3.30 | 4.18 | 1 | CL |
| 5 | VCP (283) | AFW | 1 | 20.125 | 0–2 | 0.61 | 3.30 | 4.84 | 1 | CL |
| 6 | PRDX6 (231) | LColC | 1 | 25.817 | 0–18 | 0.44 | 4.41 | 2.18 | 8 | – |
| 6 | MDH1 (169) | LColC | 14 | 27.870 | 0–22 | 0.15 | 0.33 | 2.18 | 8 | – |
| 6 | GLUD1 (319) | LL* | 36 | 20.153 | 10–48 | 2.02 | 3.80 | 2.54 | 8 | PL |
| 7 | PGAM1 (230) | TSW | 37 | 33.005 | 32–66 | 0.03 | 4.33 | 0.80 | 12 | – |
| 7 | AKR1A1 (149) | TSW | 42 | 38.135 | 33–45 | 0.03 | 0.98 | 0.80 | 12 | CL |
| 7 | PGAM1 (230) | BWbeg | 61 | 26.099 | 44–70 | 0.61 | 4.33 | 4.54 | 12 | – |
| 7 | GLUD1 (319) | TSW | 63 | 32.601 | 53–70 | 0.11 | 4.16 | 0.80 | 12 | – |
| 7 | GLUD1 (319) | BWbeg | 65 | 27.396 | 58–70 | 0.40 | 4.16 | 4.54 | 12 | – |
| 7 | APOA1 (270) | TSW | 69 | 38.558 | 61–70 | 0.01 | 0.06 | 0.80 | 12 | PL |
| 7 | APOA1 (270) | BWbeg | 69 | 38.103 | 62–70 | 0.04 | 0.06 | 4.54 | 12 | CL |
| 8 | PRPS2 (192) | Menergy | 0 | 23.879 | 0–9 | 1.20 | 1.25 | 2.72 | 10 | CL |
| 8 | PRDX4 (237) | Menergy | 5 | 22.179 | 0–13 | 1.84 | 4.65 | 2.72 | 10 | CL |
| 9 | FABP7 (318) | BW12 | 21 | 22.066 | 11–35 | 1.66 | 3.97 | 2.45 | 11 | PL |
| 9 | HISTH4 (315) | pmSFW | 80 | 23.876 | 49–83 | 0.81 | 3.84 | 4.06 | 11 | CL |
| 10 | HIBCH (151) | GLU 2nd M | 12 | 31.044 | 4–21 | 0.03 | 0.03 | 0.81 | 9 | PL |
| 12 | PRDX6 (226) | CHO 2nd M | 61 | 23.217 | 37–66 | 1.00 | 3.04 | 3.33 | 26 | CL |
| 14 | PDHA1 (133) | Mb* | 0 | 19.704 | 0–9 | 2.33 | 3.75 | 3.67 | 14 | – |
| 14 | ADK (136) | Mb* | 0 | 19.395 | 0–8 | 2.71 | 3.15 | 3.67 | 14 | – |
| 14 | HIBCH (151) | TG 2nd M | 40 | 21.241 | 27–69 | 1.34 | 2.93 | 2.44 | 14 | – |
| 14 | HIBCH (151) | CHO 20th M | 69 | 27.010 | 45–69 | 0.17 | 2.93 | 4.90 | 14 | – |
| 15 | PSMC3 (116) | CHO 2nd M | 29 | 19.869 | 11–40 | 2.63 | 4.38 | 4.94 | 6 | CL |
| 15 | MPST (188) | CHO 2nd M | 33 | 19.938 | 22–48 | 2.58 | 4.16 | 4.94 | 6 | PL |
| 15 | ENO1 (124) | CHO 2nd M | 35 | 24.632 | 26–50 | 0.63 | 0.73 | 4.94 | 6 | CL |
| 15 | ANXA5 (207) | CHO 2nd M | 35 | 21.660 | 25–48 | 1.52 | 3.25 | 4.94 | 6 | – |
| 15 | CCT7 (294) | MR | 40 | 26.662 | 30–48 | 0.29 | 0.56 | 0.77 | 6 | CL |
| 15 | ENO1 (124) | MR | 43 | 28.102 | 30–52 | 0.19 | 0.73 | 0.77 | 6 | PL |
| 15 | ENO1 (112) | MR | 53 | 24.743 | 44–57 | 0.49 | 1.20 | 0.77 | 6 | PL |
| 18 | PGAM1(325) | CortL | 0 | 26.128 | 0–37 | 0.53 | 2.27 | 4.86 | 10 | – |
| 18 | PGAM1 (232) | CortL | 0 | 27.844 | 0–12 | 0.26 | 1.01 | 4.86 | 10 | – |
| 18 | PRDX3 (257) | CortL | 5 | 30.485 | 0–12 | 0.15 | 0.43 | 4.86 | 10 | – |
| 18 | MDH1 (179) | CortL | 11 | 28.325 | 0–15 | 0.16 | 1.40 | 4.86 | 10 | – |
| 18 | GLUL (131) | CortL | 13 | 28.171 | 8–16 | 0.32 | 1.07 | 4.86 | 10 | – |
| 18 | VCP (285) | CortL | 17 | 22.468 | 0–37 | 1.85 | 4.52 | 4.86 | 10 | – |
| 18 | GDI2 (301) | CortL | 18 | 27.892 | 15–27 | 0.35 | 1.34 | 4.86 | 10 | – |
| 19 | PARK7 (263) | LProtC | 0 | 19.718 | 0–21 | 1.95 | 2.45 | 4.37 | 6 | CL |
| 19 | EIF3I (180) | LProtC | 3 | 20.937 | 0–7 | 1.29 | 1.95 | 4.37 | 6 | CL |
| 19 | EIF3I (180) | CHO 2nd M | 4 | 26.900 | 0–7 | 0.19 | 1.95 | 3.31 | 6 | – |
| 19 | PARK7 (263) | CHO 2nd M | 4 | 24.653 | 0–8 | 0.37 | 2.45 | 3.31 | 6 | – |
| 19 | ACP1 (274) | CHO 2nd M | 4 | 25.729 | 0–6 | 0.29 | 2.00 | 3.31 | 6 | – |
| 19 | EEF2 (306) | CHO 2nd M | 4 | 20.905 | 0–20 | 1.12 | 4.69 | 3.31 | 6 | – |
| 19 | EIF3I (180) | BW28 | 4 | 24.539 | 0–12 | 0.38 | 1.95 | 2.71 | 6 | PL |
| 19 | ACP1 (274) | BW28 | 4 | 22.269 | 0–8 | 0.73 | 2.00 | 2.71 | 6 | PL |
| 19 | EIF3I (180) | BWG12-28 | 4 | 22.948 | 0–16 | 0.62 | 1.95 | 3.39 | 6 | PL |
| 19 | ACP1 (274) | BWG12-28 | 4 | 22.473 | 0–8 | 0.82 | 2.00 | 3.39 | 6 | PL |
| 19 | PARK7 (263) | BWG12-28 | 6 | 23.640 | 0–20 | 0.46 | 2.45 | 3.39 | 6 | – |
| 19 | PARK7 (263) | BW28 | 6 | 23.817 | 0–20 | 0.49 | 2.45 | 2.71 | 6 | CL |
| 19 | EEF2 (306) | BWG12-28 | 16 | 22.160 | 0–20 | 0.83 | 4.69 | 3.39 | 6 | – |
| 19 | EEF2 (306) | BW28 | 33 | 22.876 | 23–41 | 0.64 | 4.69 | 2.71 | 6 | PL |
| 21 | ENO1 (112) | MFmax | 46 | 18.664 | 41–57 | 3.72 | 5.00 | 4.84 | 12 | CL |
| 21 | HAAO (196) | MFmax | 46 | 20.570 | 41–55 | 2.04 | 2.12 | 4.84 | 12 | CL |
| 21 | ALB (290) | MFmax | 55 | 20.368 | 44–58 | 0.11 | 4.63 | 4.84 | 12 | CL |
| 22 | BPNT1 (156) | BWG28-42 | 0 | 19.784 | 0–10 | 1.17 | 2.67 | 3.87 | 4 | – |
| 22 | PRDX4 (309) | Lb* | 0 | 23.820 | 0–4 | 0.28 | 0.83 | 0.98 | 4 | PL |
| 22 | CA2 (227) | BWG28-42 | 9 | 19.204 | 0–10 | 1.63 | 3.26 | 3.87 | 4 | – |
| 22 | CA2 (227) | Lb* | 9 | 22.351 | 0–10 | 0.51 | 3.26 | 0.98 | 4 | – |
| Z | GLUD1 (319) | GLU 2nd M | 7 | 25.930 | 5–11 | 0.29 | 1.13 | 1.22 | 6 | PL |
| Z | TPI1 (236) | MpHu | 23 | 30.798 | 18–34 | 0.01 | 0.63 | 0.29 | 6 | PL |
| Z | ENO1 (144) | MpHu | 23 | 28.755 | 17–35 | 0.06 | 4.84 | 0.29 | 6 | CL |
| Z | ALDH7A1 (300) | MpHu | 30 | 28.204 | 22–35 | 0.11 | 4.99 | 0.29 | 6 | – |
| Z | PSMA1 (212) | MpHu | 32 | 30.809 | 31–35 | 0.05 | 1.14 | 0.29 | 6 | – |
| Z | ATP5B (103) | MpHu | 32 | 27.477 | 31–35 | 0.14 | 2.51 | 0.29 | 6 | PL |
Only 2t-QTL for which the P value is more significant than that of the stronger of the two QTL detected using the single-trait approach are reported in this table. These results were used to identify 16 assumed pleiotropic QTL
aDuck (Anas platyrhynchos) APL chromosome or linkage group
bProtein descriptions: see supplementary data
cPosition on the genetic map in centiMorgans
dConfidence interval in centiMorgans
eCLIPtest: CL, close linkage; PL, pleiotropism; –, not tested
Fig. 6Graphs inferred from two-trait QTL detection with pleiotropy. These graphs are a representation of the data from Table 2. The chromosome locations are illustrated in green with the APL chromosome number and the location in cM. The phenotypic traits are in blue and the proteins are in red associated with the spot number. A weight is given for links (in bold) when a pleiotropic QTL was detected. The size of the nodes (proteins or phenotypes) is related to the betweenness (calculated by Gephi), i.e. an indicator of centrality that identifies the most important nodes within a graph
Two-trait QTL detections of different spots of the same protein traits reveal two pleiotropic QTL
| APLa | Proteinb | Spot numberc | Location (cM)d | LRTx | Confidence intervale | biQTL threshold (%) | UniQTL threshold (%) | CLIPTestf | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 15 | ENO1 | 112–124 | 51 | 26.220 | 41–57 | 0.41 | 0.73 | 1.20 | 6g | PL |
| 18 | PGAM1 | 232–325 | 0 | 31.645 | 0–11 | 0.12 | 1.01 | 2.27 | 10 | – |
| 24 | APOA1 | 174–262 | 22 | 29.271 | 10–29 | 0.05 | 0.78 | 1.95 | 5 | CL |
| 25 | ENO1 | 108–124 | 37 | 24.025 | 27–39 | 0.35 | 2.29 | 3.32 | 6 | – |
| 25 | ENO1 | 108–304 | 38 | 28.653 | 34–39 | 0.14 | 2.29 | 0.40 | 6 | – |
| 29 | ENO1 | 124–307 | 14 | 16.435 | 4–19 | 3.69 | 3.94 | 5.02 | 4 | PL |
aDuck (Anas platyrhynchos) APL chromosome or linkage group
bProtein descriptions: see supplementary data
cSpot number on the 2D gels
dPosition on the genetic map in centiMorgans
eConfidence interval in centiMorgans
fCLIP test: CL, close linkage; PL, pleiotropy;–, nontested
gnumber of markers
Functional enrichment analysis of canonical pathways between proteins with pQTL and the complete list of proteins
| Ingenuity canonical pathways | Complete | pQTL | Proteins with pQTL in italic | ||
|---|---|---|---|---|---|
| Regulated | Scorea | Regulated | Scorea | ||
| Mitochondrial dysfunction | 9/171 (5%) | 7.22 | 7/171 (4%) | 6.18 |
|
| Gluconeogenesis I | 4/25 (16%) | 5.40 | 4/25 (16%) | 6.10 |
|
| NRF2-mediated oxidative stress response | 7/180 (4%) | 4.85 | 6/180 (3%) | 4.84 |
|
| Glycolysis I | 3/25 (12%) | 3.76 | 3/25 (12%) | 4.28 |
|
| Acetyl-CoA biosynthesis I | 3/7 (43%) | 5.56 | 2/7 (29%) | 3.76 |
|
| LXR/RXR activation | 5/121 (4%) | 3.72 | 4/121 (3%) | 3.36 |
|
| FXR/RXR activation | 5/126 (4%) | 3.64 | 4/126 (3%) | 3.29 | |
| Caveolar-mediated endocytosis signaling | 3/71 (4%) | 2.43 | 3/71 (4%) | 2.93 |
|
| Acute phase response signaling | 5/169 (3%) | 3.06 | 4/169 (2%) | 2.82 |
|
| TR/RXR activation | 3/85 (4%) | 2.21 | 3/85 (4%) | 2.70 |
|
| Tryptophan degradation X | 4/23 (17%) | 5.55 | 2/23 (9%) | 2.69 | ALDH2, |
| Ethanol degradation II | 4/35 (11%) | 4.79 | 2/35 (6%) | 2.33 | |
| Noradrenaline and adrenaline degradation | 4/38 (11%) | 4.65 | 2/38 (5%) | 2.26 | |
| Clathrin-mediated Endocytosis signaling | 5/185 (3%) | 2.88 | 4/185 (2%) | 2.67 |
|
Only the top 14 canonical pathways are in this table
Proteins regulated by a pQTL are in italics; pQTL may concern only a sub-list of the complete list of proteins identified by proteomic analysis
aScore corresponds to −log(P value)
Fig. 7Biological network. This biological network was constructed with the proteins that are regulated by a QTL and associated with a significant enrichment score using Ingenuity Pathway Analysis software. Other information was added, such as some significant biological functions and canonical pathways (links in orange), proteins involved in cell viability are indicated with an asterisk. One trait related to liver function, i.e. melting rate, which is controlled by a pleiotropic QTL on APL15 (links in blue) was added
Functional enrichment analysis of biological functions between proteins with pQTL and the complete list of proteins
| Diseases or function annotation (Ingenuity) | Complete | pQTL | ||||
|---|---|---|---|---|---|---|
|
| Number of molecules | Rank |
| Number of molecules | Rank | |
| Synthesis of purine nucleotide | 9.97E−10 | 11 | 6 | 5.69E−09 | 9 | 1 |
| Metabolism of nucleic acid component or derivative | 7.89E−12 | 20 | 1 | 6.02E−09 | 14 | 2 |
| Metabolism of dicarboxylic acid | 2.21E−07 | 5 | 16 | 2.91E−08 | 5 | 3 |
| Metabolism of nucleotide | 2.07E−09 | 16 | 7 | 5.88E−08 | 12 | 4 |
| Metabolism of hydrogen peroxide | 2.63E−10 | 10 | 2 | 1.03E−07 | 7 | 5 |
| Cell viability | 6.29E−07 | 24 | 26 | 1.13E−07 | 20 | 6 |
| Metabolism of nucleoside triphosphate | 2.3E−08 | 9 | 11 | 3.14E−07 | 7 | 7 |
| Cell viability of tumor cell lines | 1.57E−05 | 16 | 41 | 3.45E−07 | 15 | 8 |
| Catabolism of hydrogen peroxide | 3.02E−10 | 6 | 4 | 3.83E−07 | 4 | 9 |
| Biosynthesis of purine ribonucleotide | 3.85E−07 | 7 | 21 | 6.28E−07 | 6 | 10 |
| Synthesis of nucleotide | 6.13E−07 | 12 | 25 | 6.86E−07 | 10 | 11 |
| Biosynthesis of nucleoside triphosphate | 5.98E−07 | 7 | 24 | 9.19E−07 | 6 | 12 |
| Polymerization of protein | 6.77E−06 | 11 | 35 | 1.06E−06 | 10 | 13 |
| Fatty acid metabolism | 1.46E−06 | 15 | 28 | 2.39E−06 | 12 | 14 |
| Synthesis of acetyl-coenzyme A | 1.64E−07 | 4 | 13 | 5.15E−06 | 3 | 15 |
Only the top 15 biological functions are shown according to Ingenuity analysis